| abstract |
This specification provides an anti-EpoR peptide. The present invention provides a peptide having the structure of the following formula (I): X 1 -SCH(A 1 )(A 2 )(A 3 )(A 4 )(A 5 )(A 6 )V(A 7 )( A 8 )-X 2 [In the formula, X 1 is the amino terminal side of the peptide, X 2 is the carboxy terminal side of the peptide, A 1 is M, or F, substituted or unsubstituted by halogen atoms or hydroxyl groups, Phenylglycine or phenethylglycine, A 2 is A, d-alanine or G, A 3 is P, homoproline or A, A 4 is M, L, A or I, A 5 Is T or A, A 6 is M, or W, F, Y, β-pertryptophan, α-naphthylalanine, β-naphthylalanine, or substituted or unsubstituted by methyl or halogen atoms Quinolinylalanine, A 7 is C, homocysteine or penicillamine, A 8 is K, R, or not present]. |